Status:
NOT_YET_RECRUITING
Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura
Lead Sponsor:
Assiut University
Conditions:
Pediatric Mmune Thrombocytopenic Purpura
Eligibility:
All Genders
1-18 years
Brief Summary
To Predicting steroid resistance on children newly diagnosed with immune thrombocytopenic purpura
Detailed Description
Immune thrombocytopenia (ITP, platelet counts \< 100 × 109/L) is the most common acquired childhood bleeding disorder, clinically characterized by a low platelet count in the absence of other throm...
Eligibility Criteria
Inclusion
- All patients diagnosed as acute immune thrombocytopenic purpura based on clinical manifestations and laboratory investigations from age of 1 years to age of 18 years.
- Gender: both six
Exclusion
- children with immune thrombocytopenic purpura below age of 1 years and above 18 years, patient with thrombocytopenic purpura with secondary causes, and chronic ITP
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06601543
Start Date
October 1 2024
End Date
November 1 2025
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.